Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder

ClinicalTrials.gov ID: NCT02045862

Public ClinicalTrials.gov record NCT02045862. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Multi-center Study to Evaluate the Long-Term Safety and Efficacy of Combination of Solifenacin Succinate With Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in Subjects With Overactive Bladder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to examine how well the combination of two medicines (solifenacin succinate and mirabegron) worked compared to each medicine alone in the treatment of bladder problems, and how safe they were for long term use.

Study identification

NCT ID
NCT02045862
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astellas Pharma Europe B.V.
Industry
Enrollment
1,829 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 17, 2014 (Actual)
Primary completion
Sep 8, 2016 (Actual)
Completion
Sep 8, 2016 (Actual)
Last update posted
Oct 31, 2024

2014 – 2016

United States locations

U.S. sites
75
U.S. states
25
U.S. cities
64
Facility City State ZIP Site status
Site US10049 Mobile Alabama 36608 —
Site US10112 Mobile Alabama 36608 —
Site US10104 Chandler Arizona 85224 —
Site US10021 Phoenix Arizona 85051 —
Site US10122 Anaheim California 92801 —
Site US10082 Hawaiian Gardens California 90716 —
Site US10132 Los Angeles California 90017 —
Site US10133 Los Angeles California 90036 —
Site US10149 Paramount California 90723 —
Site US10003 San Diego California 92120 —
Site US10106 Tarzana California 91356 —
Site US10595 Valley Village California 91607 —
Site US10053 Wheat Ridge Colorado 80033 —
Site US10060 Bradenton Florida 34208 —
Site US10097 Hialeah Florida 33012 —
Site US10148 Hialeah Florida 33016 —
Site US10153 Hialeah Florida 33016 —
Site US10091 Jupiter Florida 33458 —
Site US10150 New Port Richey Florida 34652 —
Site US10124 Orlando Florida 32803 —
Site US10134 Orlando Florida 32806 —
Site US10009 Pembroke Pines Florida 33027 —
Site US10554 Plantation Florida 33317 —
Site US10037 Alpharetta Georgia 30005 —
Site US10127 Roswell Georgia 30076 —
Site US10120 Sandy Springs Georgia 30328 —
Site US10078 Wichita Kansas 67205 —
Site US10088 Lake Charles Louisiana 70601 —
Site US10025 Shreveport Louisiana 71106 —
Site US10558 Hanover Maryland 21076 —
Site US10282 Boston Massachusetts 02131 —
Site US10114 Watertown Massachusetts 02472 —
Site US10110 Billings Montana 59102 —
Site US10154 Missoula Montana 59801 —
Site US10553 Lincoln Nebraska 68510 —
Site US10002 Englewood New Jersey 07631 —
Site US10047 Lawrenceville New Jersey 08648 —
Site US10011 Albuquerque New Mexico 87102 —
Site US10015 Albuquerque New Mexico 87109 —
Site US10026 Garden City New York 11530 —
Site US10040 Kingston New York 12401 —
Site US10168 New York New York 10065 —
Site US10126 Newburgh New York 12550 —
Site US10028 Poughkeepsie New York 12601 —
Site US10076 Concord North Carolina 28025 —
Site US10129 Raleigh North Carolina 27609 —
Site US10062 Winston-Salem North Carolina 27103 —
Site US10050 Cleveland Ohio 44122 —
Site US10067 Wadsworth Ohio 44281 —
Site US10109 Oklahoma City Oklahoma 73112 —
Site US10541 Medford Oregon 97504 —
Site US10008 Bala-Cynwyd Pennsylvania 19004 —
Site US10017 Philadelphia Pennsylvania 19114 —
Site US10167 Pittsburgh Pennsylvania 15213 —
Site US10250 Pittsburgh Pennsylvania 15236 —
Site US10248 Pittsburgh Pennsylvania 15243 —
Site US10063 Uniontown Pennsylvania 15401 —
Site US10012 West Reading Pennsylvania 19611 —
Site US10166 Charleston South Carolina 29425 —
Site US10079 Mt. Pleasant South Carolina 29464 —
Site US10023 Simpsonville South Carolina 29681 —
Site US10101 Summerville South Carolina 29485 —
Site US10006 Kingsport Tennessee 37660 —
Site US10065 Corpus Christi Texas 78414 —
Site US10085 Houston Texas 77058 —
Site US10219 Houston Texas 77094 —
Site US10093 Houston Texas 77099 —
Site US10090 Hurst Texas 76054 —
Site US10105 San Antonio Texas 78229 —
Site US10111 San Antonio Texas 78229 —
Site US10083 Virginia Beach Virginia 23462 —
Site US10013 Burien Washington 98166 —
Site US10004 Mountlake Terrace Washington 98043 —
Site US10155 Seattle Washington 98105 —
Site US10135 Walla Walla Washington 99362 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 176 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02045862, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2024 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02045862 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →